About Us
Mission
Leadership
Contact Us
Careers
Technology
Background
OncoSec Medical System™
OMS ElectroChemotherapy
OMS ElectroImmunotherapy
Clinical Development
Market Opportunity
OMS ElectroChemotherapy
OMS ElectroImmunotherapy
Clinical Trials
Investor Relations
Welcome
Corporate Governance
News Releases
Financial Reporting
Analyst Coverage
Events and Webcasts
Investor Alerts
Multimedia
Information Request
Investor Kit
Key Contacts
OncoSec Live!
Press Releases
CEO Blog
Press Releases
Keyword Search
May 10, 2012
OncoSec to Present at Upcoming Investor Conference
April 23, 2012
OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
April 10, 2012
OncoSec Executive Team Contributes to Manufacturing Chemist and Company Profile Featured in San DiegoBusiness Journal
March 28, 2012
OncoSec Closes $7.75 Million Public Offering
March 26, 2012
OncoSec Announces $7.75 Million Public Offering
March 22, 2012
OncoSec Selected to Present Data at Upcoming Head and Neck Cancer Conferences
March 19, 2012
Co-Principal Investigator for OncoSec’s Phase II Merkel Cell Carcinoma Study to Speak at 70th Annual American Academy of Dermatology Meeting
March 14, 2012
OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial
March 13, 2012
OncoSec President and CEO Contributes to Today's Medical Developments
March 8, 2012
OncoSec to Evaluate Potential Predictive or Prognostic Biomarkers for Treatment of Solid Tumor Cancers Using OMS ElectroImmunotherapy
March 7, 2012
OncoSec’s OMS ElectroImmunotherapy Technology Platform and its Ongoing Phase II Merkel Cell Carcinoma ClinicalTrial Featured in Seattle Newspaper
March 5, 2012
OncoSec to Present at Cowan and ROTH Healthcare Conferences
February 29, 2012
OncoSec’s OMS ElectroOncology Technology Platform featured in Medical Device & Diagnostic Industry
February 28, 2012
OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma
February 24, 2012
OncoSec to Present at 10th Annual BioPartnering North America
February 13, 2012
OncoSec Initiates Phase II Merkel Cell Carcinoma Study and Doses Several Patients
February 8, 2012
OncoSec to Present at BIO CEO & Investor Conference
February 1, 2012
OncoSec President and CEO Contributes to Physicians News Digest
January 24, 2012
OncoSec to Present at World Cancer Immunotherapy Conference
January 18, 2012
OncoSec Provides Company Update and Announces 2012 Goals
January 16, 2012
OncoSec Medical President and CEO Contributes to Drug Discovery News
January 5, 2012
OncoSec to Attend 30th Annual JP Morgan Healthcare Conference and Present at Investor Conferences in San Francisco
December 14, 2011
OncoSec Medical Engages the Investor Relations Group
December 9, 2011
OncoSec to Present at the 22nd Annual Oppenheimer Healthcare Conference
November 28, 2011
OncoSec to Present at 15th Annual Biotech and Specialty Pharmaceuticals Conference
November 23, 2011
OncoSec Appoints Scientific Advisory Board
November 16, 2011
OncoSec and Serametrix Collaborate to Identify Potential Biomarkers to Enhance Skin Cancer Immune Therapies
November 14, 2011
OncoSec to Present at Medical Device Investor Forum
October 20, 2011
Device Master File for OncoSec Medical System Completed and Submitted to FDA
October 5, 2011
OncoSec Releases Devices For Use In Clinical Trials
October 4, 2011
OncoSec to Present at Cancer Immunotherapy Conference
September 26, 2011
UPDATE: OncoSec Announces Positive Results from Head & Neck and Breast Cancer Trials
September 22, 2011
OncoSec Medical to Attend 6th Annual Fire, Ice and Beyond: The Future of Ablation Therapies Conference
September 6, 2011
OncoSec Medical to Present at Investor Conferences
August 24, 2011
OncoSec Medical to Present at Industry and Investor Conferences
August 15, 2011
OncoSec’s Cancer Clinical Trial Strategy Featured in BioWorld Magazine
July 11, 2011
OncoSec Medical to Present at DNA Vaccines Conference 2011
July 5, 2011
OncoSec Medical Appoints Engineering Leader
June 24, 2011
OncoSec Closes $3.0 Million Private Placement
June 21, 2011
OncoSec Announces $3.0 Million Private Placement Transaction
June 16, 2011
OncoSec Medical Announces the Appointment of Dr. Anthony E. Maida, III, to its Board of Directors
June 15, 2011
OncoSec Medical Reports Third Quarter 2011 Financial Results
June 14, 2011
OncoSec Announces Clinical Leadership Appointments
June 10, 2011
OncoSec ElectroImmunotherapy Shows Systemic Effects of Metastatic Melanoma Tumor in More than 50% of Patients
June 2, 2011
OncoSec Medical Clinical Adviser Will Present ElectroImmunotherapy Results From Melanoma Clinical Trial at 2011 ASCO Annual Meeting
May 26, 2011
OncoSec Medical to Initiate Multiple Phase II Skin Cancer Clinical Trials
May 11, 2011
OncoSec Announces Leadership Team Appointments
May 9, 2011
OncoSec Medical Featured in Medical Device Daily
May 6, 2011
OncoSec, not your typical startup by a long shot
April 4, 2011
OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals
March 31, 2011
OncoSec Medical Closes $1.1M Financing
March 15, 2011
OncoSec Medical to Present at ROTH 23rd Annual Growth Stock Conference
March 15, 2011
OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
March 14, 2011
OncoSec Medical Appoints Punit Dhillon as President and CEO
RSS Feed
Oncosec Stock Quote
Subscribe To Our Newsletter
Investor Presentation
Download OncoSec Medical's Corporate Profile Powerpoint
Investor Fact Sheet
Download OncoSec Medical's Investor Fact Sheet
2012 Goals
Click here
to view our 2012 Corporate Goals
RSS Feed
